Raghu Kalluri and Douglas Hanahan interviewed by Alex Gann [camera view of Kalluri only]

Preserved in 2020-2022 through a CLIR Recordings at Risk grant. This interview video is available for use under a CC0 1.0 Universal license.

Raghu Kalluri is chairman and professor of the Department of Cancer Biology and the director of the Metastasis Research Center at the University of Texas MD Anderson Cancer Center, where he also holds the Rebecca and Joseph Brown Endowed Chair. After completing his B.S. in Chemistry and Genetics, Dr. Kalluri earned his Ph.D. in Biochemistry and Molecular Biology from the University of Kansas Medical Center and his M.D. degree from Brown University Medical School. Following his postdoctoral training and work as a research associate in kidney immunology and tissue injury/repair at the University of Pennsylvania Medical School, he moved to Harvard Medical School (HMS) in 1997 as an Assistant Professor of Medicine and as a faculty member based in the Department of Medicine at the Beth Israel Deaconess Medical Center. Dr. Kalluri was named Associate Professor and the Director of the Center for Matrix Biology in 2000. Dr. Kalluri has received many honors and awards, including the Jacob Henle Medal from the Georg-August University in Germany in 2015 in honor of his contributions to medical research. He is the fellow of American Society of Clinical Investigation and the American Association for the Advancement of Science and also received several mentorship and teaching recognition awards from the Beth Israel Deaconess Medical Center and Harvard Medical School.

Dr. Douglas Hanahan is a biologist, professor and director emeritus of the Swiss Institute for Experimental Cancer Research at Ecole Polytechnique Federale de Lausanne. He is currently member of the Lausanne branch of the Ludwig Institute. He received his PhD from Harvard University in 1983. In the same year he developed Super Optimal broth, a microbiological growth medium. He has received the lifetime Achievement Award from the American Association for Cancer Research and an honorary degree from the University of Dundee in the UK and is an elected member of the American Academy of Arts and Sciences, the U.S. Institute of Medicine, the U.S. National Academy of Science and the European Molecular Biology Organization. Dr. Hanahan’s current research includes studies on genetic signatures and physical cues in the microenvironment that modulate tumor invasion and metastasis, with the hope of advancing knowledge of cancer mechanisms and therapeutic applications.